(CRSP)

Markets

CRISPR Therapeutics AG (CRSP) is expecting 32.33% growth in the next quarter: What can investors do to maximize their returns?

Steve Mayer

On Friday, CRISPR Therapeutics AG (NASDAQ: CRSP) opened lower -6.98% from the last session, before settling in for the closing ...

Analyst Insights

CRISPR Therapeutics AG (CRSP) volume hits 1.95 million: A New Opening for Investors

Sana Meer

Witnessing the stock’s movement on the chart, on N/A, CRISPR Therapeutics AG (NASDAQ: CRSP) set off with pace as it ...

News Daemon
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.